YD Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	0.47	3.13	0.09
Cash & Short-Term Investments	0.47	3.13	0.09
Cash Growth	-83.07%	3496.29%	-
Accounts Receivable	0.1	0.1	0.1
Inventory	0.37	0.04	0.07
Other Current Assets	0.45	0.19	0.02
Total Current Assets	1.4	3.47	0.27
Net Property, Plant & Equipment	0.08	0.09	0.01
Other Intangible Assets	2.9	2.68	-
Long-Term Investments	-	-	0.01
Other Long-Term Assets	1.46	0.63	0.02
Total Assets	5.84	6.86	0.32
Accounts Payable	0.04	0.03	0.02
Accrued Expenses	0.63	0.18	0.02
Current Portion of Long-Term Debt	-	-	0.03
Current Portion of Leases	0.02	0.02	0.01
Other Current Liabilities	0.06	0.04	0.22
Total Current Liabilities	0.75	0.26	0.3
Long-Term Leases	-	0.01	-
Other Long-Term Liabilities	-	0.01	-
Total Long-Term Liabilities	-	0.01	-
Total Liabilities	0.75	0.27	0.3
Common Stock	0.14	0.14	0.11
Additional Paid-in Capital	8.33	8.33	0.39
Accumulated Other Comprehensive Income	0.46	0.05	0.05
Retained Earnings	-3.84	-1.93	-0.52
Shareholders' Equity	5.09	6.59	0.02
Total Liabilities & Equity	5.84	6.86	0.32
Total Debt	0.02	0.02	0.05
Net Cash (Debt)	0.45	3.11	0.04
Net Cash Growth	-85.41%	7769.12%	-
Net Cash Per Share	453.75	3110.03	0.04
Book Value	5.09	6.59	0.02
Book Value Per Share	5088.15	6590.25	0.02
Tangible Book Value	2.19	3.91	0.02
Tangible Book Value Per Share	2186.62	3910.21	0.02

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q